SEELOS THERAPEUTICS, INC.

Insiders Seelos Therapeutics, Inc.

Equities

SEEL

US81577F2083

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
0.268 ^USD	-5.03%		-21.01%	-80.72%

04-29	Seelos Therapeutics, Inc. Announces Appointment of Richard Pascoe as Chairman of the Board of Directors	CI
03-19	Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seelos Therapeutics, Inc. Announces Appointment of Richard Pascoe as Chairman of the Board of Directors	04-29	CI
Seelos Therapeutics Insider Bought Shares Worth $100,223, According to a Recent SEC Filing	12-01	MT
Judith Dunn, a Class III Director on the Board of Directors of Seelos Therapeutics, Inc. Notifies to Resign from the Board	21-09-02	CI
Seelos Therapeutics Announces Appointment of Margaret Dalesandro to the Board of Directors	21-09-02	CI
Seelos Therapeutics : Names CFO, Chief Communications Officer	21-09-01	MT
Seelos Therapeutics, Inc. Announces Promotion of Anthony Marciano to Chief Communications Officer	21-09-01	CI
Seelos Therapeutics, Inc. Announces Executive Appointments	21-01-06	CI
Seelos Therapeutics Announces Appointment of Judith Dunn to the Board of Directors	20-05-15	CI
Seelos Therapeutics, Inc. Announces Board Changes	20-03-30	CI
Seelos Therapeutics, Inc. Announces Appointment of Scott Applebaum as Lead Strategic Regulatory Consultant	19-10-15	CI
Seelos Therapeutics, Inc. Appoints Warren W. Wasiewski as Chief Scientific Officer	19-08-01	CI
Seelos Therapeutics, Inc. Announces Executive Changes	19-01-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW